The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cohen Yuval since 2014.
This trader's CIK number is 1626003.
At the time of last reporting, Cohen Yuval was the Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc.. (stock ticker symbol CRBP).
Also see all insider trading activities at Corbus Pharmaceuticals Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CRBP | 0 | $0 | 63,358 | $2,950,508 | 63,358 | $749,038 |
| 2022 | CRBP | 22,900 | $6,810 | 0 | $0 | 0 | $0 |
| 2020 | CRBP | 8,540 | $20,133 | 0 | $0 | 0 | $0 |
| 2019 | CRBP | 5,130 | $30,090 | 0 | $0 | 0 | $0 |
| 2018 | CRBP | 2,885 | $18,077 | 0 | $0 | 0 | $0 |
| 2017 | CRBP | 5,945 | $36,878 | 0 | $0 | 20,000 | $20,000 |
| 2016 | CRBP | 4,965 | $20,347 | 0 | $0 | 20,000 | $20,000 |
| 2015 | CRBP | 4,935 | $10,460 | 0 | $0 | 0 | $0 |
| 2014 | CRBP | 1,900 | $6,314 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-14 | CRBP | Option Ex | 29,317 | 9.18 | 269,130 |
| 2024-06-14 | CRBP | Sale | 29,317 | 50.17 | 1,470,716 |
| 2024-06-17 | CRBP | Option Ex | 11,103 | 17.13 | 190,194 |
| 2024-06-18 | CRBP | Option Ex | 15,759 | 16.12 | 254,035 |
| 2024-06-17 | CRBP | Sale | 11,103 | 46.02 | 510,960 |
| 2024-06-18 | CRBP | Sale | 22,938 | 42.24 | 968,832 |
| 2024-01-26 | CRBP | Option Ex | 7,179 | 4.97 | 35,679 |
| 2022-08-10 | CRBP | Buy | 3,800 | .26 | 1,003 |
| 2022-05-16 | CRBP | Buy | 10,500 | .25 | 2,625 |
| 2022-03-09 | CRBP | Buy | 8,600 | .37 | 3,182 |
| 2020-11-11 | CRBP | Buy | 4,240 | 1.21 | 5,126 |
| 2020-03-17 | CRBP | Buy | 4,300 | 3.49 | 15,007 |
| 2019-11-12 | CRBP | Buy | 1,430 | 4.26 | 6,091 |
| 2019-08-12 | CRBP | Buy | 1,175 | 6.06 | 7,115 |
| 2019-05-13 | CRBP | Buy | 995 | 6.99 | 6,955 |
| 2019-03-14 | CRBP | Buy | 1,530 | 6.49 | 9,929 |
| 2018-05-15 | CRBP | Buy | 1,725 | 5.85 | 10,091 |
| 2018-03-14 | CRBP | Buy | 1,160 | 6.88 | 7,986 |
| 2017-11-10 | CRBP | Buy | 1,000 | 7.17 | 7,169 |
| 2017-08-11 | CRBP | Buy | 1,695 | 6.00 | 10,170 |
| 2017-05-11 | CRBP | Buy | 3,250 | 6.01 | 19,539 |
| 2017-03-16 | CRBP | Option Ex | 20,000 | 1.00 | 20,000 |
| 2016-11-22 | CRBP | Buy | 1,340 | 7.64 | 10,237 |
| 2016-08-17 | CRBP | Option Ex | 20,000 | 1.00 | 20,000 |
| 2016-06-06 | CRBP | Buy | 1,500 | 3.34 | 5,010 |
| 2016-05-18 | CRBP | Buy | 2,125 | 2.40 | 5,100 |
| 2015-11-23 | CRBP | Buy | 535 | 1.76 | 941 |
| 2015-11-13 | CRBP | Buy | 850 | 1.73 | 1,470 |
| 2015-08-24 | CRBP | Buy | 550 | 1.95 | 1,070 |
| 2015-08-17 | CRBP | Buy | 2,100 | 1.92 | 4,027 |
| 2015-06-15 | CRBP | Buy | 900 | 3.28 | 2,952 |
| 2014-12-17 | CRBP | Buy | 400 | 3.66 | 1,464 |
| 2014-12-04 | CRBP | Buy | 500 | 3.30 | 1,650 |
| 2014-12-03 | CRBP | Buy | 1,000 | 3.20 | 3,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cohen Yuval (Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.